Ileocecal resection may have role as ‘primary treatment’ in recently diagnosed Crohn’s

CHICAGO — Patients who underwent ileocecal resection for Crohn’s disease had a 33% lower risk for hospitalization, repeat surgery, systemic corticosteroid exposure and perianal CD, according to a presenter at Digestive Disease Week.“The LIR!C trial has demonstrated comparable quality of life with ileocecal resection compared to infliximab as a first-line treatment for limited, non-stricturing ileocecal CD,” Manasi Agrawal, MD, MS, assistant professor of medicine at Icahn School of Medicine and gastroenterologist at Mount Sinai Hospital, told Healio. “However,Read More